Skip to Main Navigation

Strengthening Lebanon’s Covid-19 Response

Abstract*

The development objective of Strengthening Lebanon's COVID-19 Response under the COVID-19 Strategic Preparedness and Response Program (SPRP) Project is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. This project has three components. 1) The first component, Procurement of COVID-19 vaccines and deployment, has the following sub-components: (i) Procurement of Vaccines and...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen Lebanon’s national system for public health preparedness.

Key Details

Project Details

  • P178587

  • Active

  • Ronald Gomez Suarez , Farah Asfahani

  • The Lebanese Republic

  • Lebanon

  • April 6, 2022

  • (as of board presentation)

    May 15, 2022

  • December 20, 2022

  • US$ 29.00 million

  • N/A

  • Substantial

  • December 31, 2025

  • Yes

  • BANK APPROVED

  • April 9, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IBRD Fund for Innovative GPG Solutions 4.00
International Bank for Reconstruction and Development 22.95
Concessional Financing Facility 2.05

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 22.95
IDA Commitment N/A
IBRD + IDA Commitment 22.95
Lending Instrument
Grant Amount 6.05
Total Project Cost** 29.00

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of April 30, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Dec 1, 2023 IBRD-94280 Int Charges 1,753.24
Dec 1, 2023 IBRD-94280 Int Charges 32.18
Jun 5, 2024 IBRD-94280 Int Charges 11.31
Jun 5, 2024 IBRD-94280 Int Charges 23,047.53
Jun 5, 2024 IBRD-94280 Int Charges 142,906.52
Jun 1, 2023 IBRD-94280 Int Charges 1,198.29
Dec 20, 2022 IBRD-94280 Fee Charges 57,375.00
Dec 20, 2022 IBRD-94280 Loan Disb 57,375.00
May 15, 2022 IBRD-94280 Loan Commitment 22,950,000.00
Nov 20, 2023 IBRD-94280 Loan Disb 4,490,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Unsatisfactory 2025-04-24
Financial Management Moderately Satisfactory 2025-04-24
Monitoring and Evaluation Satisfactory 2025-04-24
Progress towards achievement of PDO Moderately Satisfactory 2025-04-24
Project Management Satisfactory 2025-04-24
Overall Implementation Progress (IP) Moderately Unsatisfactory 2025-04-24

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of COVID-19 vaccine doses acquired through project financingValue0.000.00800000.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of residents of Lebanon who are fully vaccinated, total and disaggregated by sex, age risk, group and nationality (including refugees and host communities).Value40.0044.0070.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Number of patients with COVID-19 and other related conditions whose treatments were supported by the project (total and disaggregated by sex)Value0.000.0014000.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of feedback cases registered in the project's grievance redress mechanism (GRM) in the last quarter addressed within a timeframe specified by the projectValue50.0050.0070.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of refugees pre-registered on the national platform who are fully vaccinated (total and disaggregated by sex)Value40.0040.0060.00
    DateJuly 1, 2022April 4, 2024September 30, 2024
    Comment
  • Number of communication initiatives supported by the project to address vaccine hesitancyValue0.000.006.00
    DateMay 3, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of designated hospitals fully equipped with commodities (e.g. PPE, testing, infection control products and supplies)Value50.0050.0070.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of vaccination sites visited by a technical auditor in the last quarter which are in compliance with Environmental and Social requirementsValue75.0075.0095.00
    DateJuly 1, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of vaccination sites visited by the technical auditor in the last quarterValue0.000.00100.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Number of health workers who received training in vaccination with gender-based violence (GBV) related contentValue0.000.000.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of interviewed vaccine recipients reporting to be satisfied with the COVID-19 vaccination service that they receivedValue85.0085.0090.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Proportion of females among Syrian vaccine recipients (received at least one dose)Value39.0039.0045.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment
  • Percentage of refugees (Syrians and Palestinians) who are pre-registered on the platformValue35.0035.0060.00
    DateMay 13, 2022April 4, 2024September 30, 2024
    Comment